




Searching News Database: Endometriosis
HSMN NewsFeed - 4 May 2020
Enteris BioPharma Appoints Rajiv Khosla, Ph.D., as Chief Executive Officer
Enteris BioPharma Appoints Rajiv Khosla, Ph.D., as Chief Executive Officer
HSMN NewsFeed - 10 Feb 2020
Enteris BioPharma Appoints Gary A. Shangold, MD, as Chief Medical Officer
Enteris BioPharma Appoints Gary A. Shangold, MD, as Chief Medical Officer
HSMN NewsFeed - 23 Oct 2012
Bovie Medical Corporation to Conduct Conference Call on J-Plasma(TM) Technology
Bovie Medical Corporation to Conduct Conference Call on J-Plasma(TM) Technology
HSMN NewsFeed - 5 Jun 2012
Abbott Announces Initiation of Phase 3 Study of Elagolix in Patients with Endometriosis
Abbott Announces Initiation of Phase 3 Study of Elagolix in Patients with Endometriosis
HSMN NewsFeed - 2 Jun 2011
Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller
Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller
HSMN NewsFeed - 25 Jan 2011
Respected Gynecologist, Lipidologist Joins Atherotech Diagnostics Lab Medical Advisory Board
Respected Gynecologist, Lipidologist Joins Atherotech Diagnostics Lab Medical Advisory Board
HSMN NewsFeed - 30 Apr 2010
Repros Receives Guidance From FDA Regarding Clinical Hold Status of Proellex(R)
Repros Receives Guidance From FDA Regarding Clinical Hold Status of Proellex(R)
HSMN NewsFeed - 28 Jan 2010
Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatment
Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatment
HSMN NewsFeed - 29 Jun 2009
DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation
DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation
HSMN NewsFeed - 13 Mar 2009
DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer
DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer
HSMN NewsFeed - 6 Jan 2009
DOR BioPharma Obtains Fast Track Designation for DOR201 in the Prevention of Acute Radiation Enteritis
DOR BioPharma Obtains Fast Track Designation for DOR201 in the Prevention of Acute Radiation Enteritis
HSMN NewsFeed - 22 May 2008
DOR BioPharma Provides Update on orBec(R) European Regulatory and Development Strategy
DOR BioPharma Provides Update on orBec(R) European Regulatory and Development Strategy
HSMN NewsFeed - 10 Mar 2008
Symbollon Pharmaceuticals Signs Term Sheet to Acquire Chinese Pharmaceutical Company
Symbollon Pharmaceuticals Signs Term Sheet to Acquire Chinese Pharmaceutical Company
HSMN NewsFeed - 12 Feb 2008
Ipsen: Clinical Update For Decapeptyl(R) 6-Month Formulation in Advanced Prostate Cancer
Ipsen: Clinical Update For Decapeptyl(R) 6-Month Formulation in Advanced Prostate Cancer
HSMN NewsFeed - 12 Feb 2008
Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer
Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer
HSMN NewsFeed - 14 Jan 2008
Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer
Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer
HSMN NewsFeed - 7 Dec 2007
DOR BioPharma Announces Results of orBec(R) End of Review Conference With the FDA
DOR BioPharma Announces Results of orBec(R) End of Review Conference With the FDA
HSMN NewsFeed - 9 Oct 2007
orBec(R) Clinical Summary Published in "Expert Opinion on Investigational Drugs"
orBec(R) Clinical Summary Published in "Expert Opinion on Investigational Drugs"
HSMN NewsFeed - 24 Sep 2007
Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
HSMN NewsFeed - 12 Jun 2007
Neurocrine Announces Resubmission of New Drug Application for Indiplon Capsules
Neurocrine Announces Resubmission of New Drug Application for Indiplon Capsules
HSMN NewsFeed - 21 May 2007
Hologic and Cytyc to Merge Creating a $10 Billion Global Leader in Women's Healthcare
Hologic and Cytyc to Merge Creating a $10 Billion Global Leader in Women's Healthcare
HSMN NewsFeed - 9 May 2007
FDA Advisory Panel Reviews DOR BioPharma's orBec(R) for Treatment of GI GVHD
FDA Advisory Panel Reviews DOR BioPharma's orBec(R) for Treatment of GI GVHD
HSMN NewsFeed - 19 Apr 2007
AEterna Zentaris Reports First Patients Treated with Cetrorelix for Phase 3 Program in BPH
AEterna Zentaris Reports First Patients Treated with Cetrorelix for Phase 3 Program in BPH
HSMN NewsFeed - 4 Apr 2007
DOR BioPharma Announces Initiation of Clinical Development Program for Oral Leuprolide
DOR BioPharma Announces Initiation of Clinical Development Program for Oral Leuprolide
HSMN NewsFeed - 4 Apr 2007
Meditrina Pharmaceuticals, Inc. Initiates Phase II Trial and Raises $4.4M in Initial Funding
Meditrina Pharmaceuticals, Inc. Initiates Phase II Trial and Raises $4.4M in Initial Funding
HSMN NewsFeed - 20 Feb 2007
Neurocrine Biosciences Announces the Resignation of Adrian Adams From the Board of Directors
Neurocrine Biosciences Announces the Resignation of Adrian Adams From the Board of Directors
HSMN NewsFeed - 22 Jan 2007
Neurocrine Announces Plans to Resubmit NDA for Indiplon Capsules in Q2 2007
Neurocrine Announces Plans to Resubmit NDA for Indiplon Capsules in Q2 2007
HSMN NewsFeed - 18 Dec 2006
Neuro Diagnostic Devices (NeuroDx) Names Industry Veteran Frederick Fritz as CEO and President
Neuro Diagnostic Devices (NeuroDx) Names Industry Veteran Frederick Fritz as CEO and President
HSMN NewsFeed - 18 Dec 2006
Repros Reports Proellex Achieves Statistically Significant Pain Reduction in Endometriosis Trial
Repros Reports Proellex Achieves Statistically Significant Pain Reduction in Endometriosis Trial
HSMN NewsFeed - 25 Oct 2006
Cytyc Acquires Minimally Invasive Surgical Device for Treating Endometriosis
Cytyc Acquires Minimally Invasive Surgical Device for Treating Endometriosis
HSMN NewsFeed - 24 Oct 2006
Repros Reports Partial Interim Assessment of Phase 2 Study of Proellex(TM) in Endometriosis
Repros Reports Partial Interim Assessment of Phase 2 Study of Proellex(TM) in Endometriosis
Additional items found! 94

Members Archive contains
94 additional stories matching:
Endometriosis
(Password required)
Endometriosis
(Password required)